Entera Bio Equity Warrants Exp 27 June 2023 ENTXW:NASDAQ

RT Quote | USD
Last | 11/23/22 EST
0.00quote price arrow down-0.061 (-100.00%)
52 week range
0.02 - 0.47
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.061
  • 52 Week High0.47
  • 52 Week High Date12/02/21
  • 52 Week Low0.02
  • 52 Week Low Date07/05/22

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.061
  • 52 Week High0.47
  • 52 Week High Date12/02/21
  • 52 Week Low0.02
  • 52 Week Low Date07/05/22
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Entera Bio Equity Warrants Exp 27 June 2023

 

Profile

MORE
Entera Bio Ltd is an Israel-based product-focused biotechnology company that specializes in the oral delivery of large molecules and biologics. The Company conducts clinical trials on its proprietary technology, which allows oral delivery of large molecules and biologics while enhancing their absorption in the gastrointestinal (GI) tract. Entera Bio Ltd's technology addresses the major problems of oral drug delivery of large molecule active pharmaceutical ingredients (APIs)....
Gerald Lieberman
Independent Chairman of the Board
Miranda Toledano
Chief Executive Officer, Director
Hillel Galitzer
Chief Operating Officer
Dana Yaacov-Garbeli
Chief Financial Officer
Address
Hadassah / Jerusalem Bio
Park, 5th Floor
Jerusalem
9112002
Israel